Increased NOX2 activity has been observed in the liver cells of NAFLD patients, leading to the release of NOX2 into the bloodstream and elevated levels of serum sp-NOX2, indicating systemic oxidant stress [58,59]. The gene discussed is CYBB; the disease is metabolic dysfunction-associated steatotic liver disease.